Millions of patients die each year due to cardiovascular disease because current therapies often fail to precisely target diseased heart tissue, says UCF’s Dinender Singla. Although treatments may require patients to take several high-dose medications, clinicians cannot actually be sure the drugs are effectively reaching the heart.
Singla is addressing this problem with an innovative drug delivery platform that puts heart medication into “smart tiny bubbles” tagged with markers that send them precisely where the drug is needed. “Our goal is to create a safe, highly targeted treatment strategy that improves patient outcomes, reduces healthcare costs and lowers global cardiovascular mortality rates — all while advancing a more personalized, effective approach to heart disease care.”
View Related Expert Profiles: Go to Source
